Laboratory of Neuronal Networks Morphology and System Biology, Department of Mental and Physical Health and Preventive Medicine, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy.
ISBE Italy, SYSBIO Centre of Systems Biology, 20126 Milan, Italy.
Cells. 2024 Oct 23;13(21):1754. doi: 10.3390/cells13211754.
Glioblastoma is the most fatal and common malignant brain tumor, excluding metastasis and with a median survival of approximately one year. While solid tumors benefit from newly approved drugs, immunotherapy, and prevention, none of these scenarios are opening for glioblastoma. The key to unlocking the peculiar features of glioblastoma is observing its molecular and anatomical features tightly entangled with the host's central nervous system (CNS). In June 2024, we searched the PUBMED electronic database. Data collection and analysis were conducted independently by two reviewers. Results: A total of 215 articles were identified, and 192 were excluded based on inclusion and exclusion criteria. The remaining 23 were used for collecting divergent molecular pathways and anatomical features of glioblastoma. The analysis of the selected papers revealed a multifaced tumor with extreme variability and cellular reprogramming that are observable within the same patient. All the variability of glioblastoma could be clustered into three pillars to dissect the physiology of the tumor: 1. necrotic core; 2. vascular proliferation; 3. CNS infiltration. These three pillars support glioblastoma survival, with a pivotal role of the neurovascular unit, as supported by the most recent paper published by experts in the field.
胶质母细胞瘤是最致命和最常见的恶性脑肿瘤,不包括转移,中位生存期约为一年。虽然实体瘤受益于新批准的药物、免疫疗法和预防措施,但这些情况都不适用于胶质母细胞瘤。解开胶质母细胞瘤特殊特征的关键是密切观察其与宿主中枢神经系统(CNS)紧密交织的分子和解剖特征。2024 年 6 月,我们搜索了 PUBMED 电子数据库。数据收集和分析由两位评审员独立进行。结果:共确定了 215 篇文章,根据纳入和排除标准排除了 192 篇。剩下的 23 篇用于收集胶质母细胞瘤的不同分子途径和解剖特征。对选定论文的分析揭示了一种具有极端可变性和细胞重编程的多面性肿瘤,这些可变性在同一患者中是可见的。所有胶质母细胞瘤的可变性都可以聚类为三个支柱,以剖析肿瘤的生理学:1. 坏死核心;2. 血管增殖;3. CNS 浸润。这三个支柱支持胶质母细胞瘤的存活,神经血管单元起着关键作用,这得到了该领域专家最近发表的一篇论文的支持。